The potential of PARP inhibitors in targeted cancer therapy and immunotherapy
DNA damage response (DDR) deficiencies result in genome instability, which is one of the hallmarks of cancer. Poly (ADP-ribose) polymerase (PARP) enzymes take part in various DDR pathways, determining cell fate in the wake of DNA damage. PARPs are readily druggable and PARP inhibitors (PARPi) agains...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2022-12-01
|
| Серія: | Frontiers in Molecular Biosciences |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fmolb.2022.1073797/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|